Comparative toxicity and dosimetric profile of whole-pelvis versus prostate bed-only intensity-modulated radiation therapy after prostatectomy

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 4, 2012, Pages 1389-1396

  Deville, Curtiland ^a   Vapiwala, Neha ^a   Hwang, Wei Ting ^b   Lin, Haibo ^a   Bar Ad, Voichita ^a   Tochner, Zelig ^a   Both, Stefan ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

IMRT; Pelvic nodal irradiation; Prostate cancer; Toxicity; Whole pelvis

Indexed keywords

ANDROGEN DEPRIVATION THERAPY; COMPARATIVE TOXICITY; COMPARISON GROUP; DOSE-VOLUME HISTOGRAMS; GASTROINTESTINAL TOXICITIES; GLEASON SCORES; IMRT; INTENSITY-MODULATED RADIATION THERAPY; LOGISTIC REGRESSION MODELS; MULTI VARIATE ANALYSIS; PRE-TREATMENT; PROSTATE CANCERS; PROSTATE SPECIFIC ANTIGEN; WHOLE PELVIS;

DISEASES; DOSIMETERS; DOSIMETRY; LOGISTICS; PATIENT TREATMENT; PHYSICAL THERAPY; POPULATION STATISTICS; REGRESSION ANALYSIS; UROLOGY;

TOXICITY;

PROSTATE SPECIFIC ANTIGEN;

ADULT; ANDROGEN DEPRIVATION THERAPY; ARTICLE; CANCER STAGING; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DOSIMETRY; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SCORING SYSTEM; UROGENITAL TRACT DISEASE;

AGED; FOLLOW-UP STUDIES; GASTROINTESTINAL TRACT; HUMANS; LYMPHATIC IRRADIATION; MALE; MIDDLE AGED; NEOPLASM GRADING; ORGANS AT RISK; PELVIS; POSTOPERATIVE CARE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; RECTUM; RETROSPECTIVE STUDIES; URINARY BLADDER; UROGENITAL SYSTEM;

EID: 84857916981     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.04.041     Document Type: Article

References (32)

1. M. Bolla, H. van Poppel, and L. Collette Postoperative radiotherapy after radical prostatectomy: A randomized controlled trial (EORTC trial 22911) Lancet 366 9485 2005 572 578
2. I.M. Thompson, C.M. Tangen, and J. Paradelo Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: Long-term followup of a randomized clinical trial J Urol 181 3 2009 956 962
3. T. Wiegel, D. Bottke, and U. Steiner Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95 J Clin Oncol 27 18 2009 2924 2930
4. A.J. Stephenson, P.T. Scardino, and M.W. Kattan Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy J Clin Oncol 25 15 2007 2035 2041
5. B.J. Trock, M. Han, and S.J. Freedland Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy JAMA 299 23 2008 2760 2769
6. M.T. Spiotto, S.L. Hancock, and C.R. King Radiotherapy after prostatectomy: Improved biochemical relapse-free survival with whole pelvic compared with prostate bed only for high-risk patients Int J Radiat Oncol Biol Phys 69 1 2007 54 61
7. B.S. Kim, A. Lashkari, R. Vongtama, S.P. Lee, and R.G. Parker Effect of pelvic lymph node irradiation in salvage therapy for patients with prostate cancer with a biochemical relapse following radical prostatectomy Clin Prostate Cancer 3 2 2004 93 97
8. F. Alongi, C. Fiorino, and C. Cozzarini IMRT significantly reduces acute toxicity of whole-pelvis irradiation in patients treated with post-operative adjuvant or salvage radiotherapy after radical prostatectomy Radiother Oncol 93 2 2009 207 212
9. C. Fiorino, F. Alongi, and L. Perna Dose-volume relationships for acute bowel toxicity in patients treated with pelvic nodal irradiation for prostate cancer Int J Radiat Oncol Biol Phys 75 1 2009 29 35
10. S. Arcangeli, B. Saracino, and M.G. Petrongari Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area Radiother Oncol 84 2 2007 148 155
11. A. Pollack A call for more with a desire for less (pelvic radiotherapy with androgen deprivation in the treatment of prostate cancer) J Clin Oncol 21 2003 1899 1901
12. M. Roach In reply [Letter] J Clin Oncol 22 2004 2255 2257
13. G. Sanguineti, E.J. Endres, and B.C. Parker Acute toxicity of whole-pelvis IMRT in 87 patients with localized prostate cancer Acta Oncol 47 2 2008 301 310
14. J.B. Ashman, M.J. Zelefsky, M.S. Hunt, S.A. Leibel, and Z. Fuks Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy Int J Radiat Oncol Biol Phys 63 3 2005 765 771
15. C. Deville, S. Both, W.T. Hwang, Z. Tochner, and N. Vapiwala Clinical toxicities and dosimetric parameters after whole-pelvis versus prostate-only intensity-modulated radiation therapy for prostate cancer Int J Radiat Oncol Biol Phys 78 3 2010 763 772
16. J.K. Ryu, K. Winter, and J.M. Michalski Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy) Int J Radiat Oncol Biol Phys 54 4 2002 1036 1046
17. J.D. Cox, J. Stetz, and T.F. Pajak Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radiat Oncol Biol Phys 31 5 1995 1341 1346
18. Cox JD, Stetz J, Pajak TF. Common Terminology Criteria for Adverse Events (CTCAE): Version 4.02. Available at: http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE-4. 02-2009-09-15-QuickReference-8.5x11.pdf. Accessed XXX February 14, 2010.
19. M.R. Cheung, S.L. Tucker, and L. Dong Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer Int J Radiat Oncol Biol Phys 67 4 2007 1059 1065
20. S.T. Peeters, M.S. Hoogeman, and W.D. Heemsbergen Volume and hormonal effects for acute side effects of rectum and bladder during conformal radiotherapy for prostate cancer Int J Radiat Oncol Biol Phys 63 4 2005 1142 1152
21. W.D. Heemsbergen, M.S. Hoogeman, G.A. Hart, J.V. Lebesque, and P.C. Koper Gastrointestinal toxicity and its relation to dose distributions in the anorectal region of prostate cancer patients treated with radiotherapy Int J Radiat Oncol Biol Phys 61 4 2005 1011 1018
22. C. Fiorino, G. Sanguineti, and C. Cozzarini Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer Int J Radiat Oncol Biol Phys 57 4 2003 953 962
23. M.R. Storey, A. Pollack, and G. Zagars Complications from radiotherapy dose escalation in prostate cancer. preliminary results of a randomized trial Int J Radiat Oncol Biol Phys 48 3 2000 635 642
24. M.J. Zelefsky, E. Aschkenasy, and S. Kelsen Tolerance and early outcome results of postprostatectomy three-dimensional conformal radiotherapy Int J Radiat Oncol Biol Phys 39 1997 327 333
25. C. Tsien, K.A. Griffith, and H.M. Sandler Long-term results of three-dimensional conformal adjuvant and salvage radiotherapy after radical prostatectomy Urology 62 2003 93 98
26. M. Feng, A.L. Hanlon, and T.M. Pisansky Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapy Int J Radiat Oncol Biol Phys 68 5 2007 1417 1423
27. G. De Meerleer, V. Fonteyne, and S. Meersschout Salvage intensity-modulated radiotherapy for rising PSA after radical prostatectomy Radiother Oncol 89 2 2008 205 213
28. S.K. Nath, A.P. Sandhu, and B.S. Rose Toxicity analysis of postoperative image-guided intensity-modulated radiotherapy for prostate cancer Int J Radiat Oncol Biol Phys 78 2 2010 435 441
29. P. Ost, V. Fonteyne, and G. Villeirs Adjuvant high-dose intensity-modulated radiotherapy after radical prostatectomy for prostate cancer: Clinical results in 104 patients Eur Urol 56 4 2009 669 675
30. J.C. Cheng, T.E. Schultheiss, K.H. Nguyen, and J.Y. Wong Acute toxicity in definitive versus postprostatectomy image-guided radiotherapy for prostate cancer Int J Radiat Oncol Biol Phys 71 2 2008 351 357
31. B.S. Teh, W.Y. Mai, and M.E. Augspurger Intensity modulated radiation therapy (IMRT) following prostatectomy: More favorable acute genitourinary toxicity profile compared to primary IMRT for prostate cancer Int J Radiat Oncol Biol Phys 49 2 2001 465 472
32. Barry MJ, Coffey DC, Fitzpatrick J, et al., Recommendations of the International Consensus Committee concerning patient evaluation for research studies. In: Cockett A.T.K, Aso Y, Chatelain C, et al. Proceedings of the International Consultation on Benign Prostatic Hyperplasia (BPH), 1991, Paris Scientific Communication International, Channel Islands (1991), pp. 279-281